Zacks Analyst Blog Features Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan
[ad_1]
For immediate release
Chicago, IL – April 27, 2022 – Zacks.com announces the list of stocks featured in the analyst blog. Every day, Zacks Equity Research analysts discuss the latest news and events impacting stocks and financial markets. Stocks recently featured in the blog include: Novo Nordisk A/S NVO, Advanced Micro Devices, Inc. AMD, Netflix, Inc. NFLX, Merck & Co., Inc. MRK, and Marsh & McLennan Companies, Inc. MMC.
Here are the highlights from Tuesday’s analyst blog:
Top research reports for Novo Nordisk, AMD and Netflix
Zacks Research Daily features top research results from our team of analysts. Today’s Research Daily features new research reports on 16 major stocks, including Novo Nordisk A/S, Advanced Micro Devices, Inc. and Netflix, Inc. These research reports have been handpicked from the few 70 reports released by our analyst team today. .
You can see all today’s research reports here >>>
Shares of Novo Nordisk have outperformed the industry Zacks Large Cap Pharmaceuticals over the past year (+53% vs. +28.4%). The diabetes drug marketed by Novo Nordisk, Ozempic, is off to a good start. The launch of Rybelsus also looks impressive. Annual growth is driven by all geographic areas. Novo Nordisk has one of the broadest diabetes portfolios in the industry. Ozempic, Rybelsus, Xultophy and Saxenda helped the company maintain momentum.
The Zacks analyst believes Label’s expansion of these existing drugs should further boost sales. However, lower prices realized in the United States, loss of product exclusivity and fierce competition are affecting sales. Sales are also negatively impacted by the COVID-19 pandemic. Additionally, Wegovy’s supply issues hurt the stock. Patent expiration on some of the products in Novo Nordisk’s portfolio is also of concern.
(You can read the full Novo Nordisk research report here >>>)
Advanced micro-systems shares have gained +2.2% over the past year against the industry’s +4.4% gain Zacks Electronics – Semiconductors. The company is benefiting from strong demand for its Ryzen and EPYC server processors, thanks to the growing proliferation of artificial intelligence (AI) and machine learning (ML) in industries such as cloud, gaming and data centers. The growing weight of 7 nanometer (nm) products in the data center vertical market, driven by work-from-home and e-learning trends, is a key enabler. AMD provided strong revenue guidance for 2022, supported by robust growth across all businesses.
Increasing revenue from servers and client processors will likely lead to a sequential increase. Acquisitions of Xilinx and Pensando will bolster AMD’s data center business. Alliances with Amazon, Microsoft, Baidu and JD.com are likely to increase business prospects. However, fierce competition from NVIDIA and Intel remains a concern.
(You can read the full research report on Advanced Micro Devices here >>>)
netflix shares are down -60.0% over the past year against Zacks Broadcast’s radio and television industry decline of -43.0%. The company is suffering from fierce competition in the streaming space like Apple, Amazon Prime Video, HBO Max, Disney+, Peacock, Paramount+ and TikTok. The company’s leveraged balance sheet and higher broadcast requirement are major concerns. Fierce competition, the adverse impact of account sharing, sluggish economic growth, rising inflation, the Russian-Ukrainian conflict, and some ongoing disruptions due to COVID-19.
However, Netflix is expected to continue dominating the streaming space, thanks to its diverse content portfolio, which is attributable to heavy investments in the production and distribution of foreign-language localized content.
(You can read the full Netflix research report here >>>)
Other noteworthy reports we’re featuring today include Merck & Co., Inc. and Marsh & McLennan Companies, Inc.
Why haven’t you watched Zacks best action?
Our top 5 performing strategies swept away the S&P’s impressive +28.8% gain in 2021. Surprisingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today, you can access their live selections at no cost or obligation.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is not indicative of future results. The potential for loss is inherent in any investment. This document is provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold any security. No recommendation or advice is given as to whether any investment is suitable for any particular investor. It should not be assumed that investments in the securities, companies, sectors or markets identified and described have been or will be profitable. All information is current as of the date hereof and is subject to change without notice. The views or opinions expressed may not reflect those of the company as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management of securities. These returns come from hypothetical portfolios composed of stocks with Zacks Rank = 1 that have been rebalanced monthly without transaction fees. These are not the returns of actual stock portfolios. The S&P 500 is an unmanaged index. To visit https://www.zacks.com/performance for more information on the performance figures displayed in this press release.
Zacks names ‘only one best choice for doubling up’
From thousands of stocks, 5 Zacks experts have each picked their favorite to skyrocket by +100% or more in the coming months. Of these 5, Research Director Sheraz Mian selects one to have the most explosive advantage of all.
It’s a little-known chemical company that’s up 65% year-on-year, but still very cheap. With relentless demand, rising earnings estimates for 2022 and $1.5 billion for stock buybacks, retail investors could jump in at any moment.
This company could rival or surpass other recent Zacks stocks which are expected to double, such as Boston Beer Company which jumped +143.0% in just over 9 months and NVIDIA which jumped +175.9% in one. year.
Free: See our best stock and our 4 finalists >>
Advanced Micro Devices, Inc. (AMD): Free Inventory Analysis Report
Novo Nordisk AS (NVO): Free Stock Analysis Report
Merck & Co., Inc. (MRK): Free Inventory Analysis Report
Netflix, Inc. (NFLX): Free Stock Analysis Report
Marsh & McLennan Companies, Inc. (MMC): Free Stock Analysis Report
To read this article on Zacks.com, click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
[ad_2]
Source link